A Phase 3 Trial To Evaluate The Safety And Efficacy Of a Drug In Patients With COPD
The purpose of this study is to determine if a treatment using an inhaler is safe and effective for the treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
Carolina Clinical Research is currently seeking study participants 18 years and older with a current COPD diagnosis .
This study is currently sponsored by Verona Pharma PLC, in collaboration with Iqvia Pty Ltd.